Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data)

Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data)

Aim. Based on the data from the register of patients with COVID-19 and community-acquired pneumonia (CAP), analyze the duration of the prehospital period, cardiovascular comorbidity and the quality of prehospital pharmacotherapy of concomitant cardiovascular diseases (CVD).Material and methods. Pati...

Full description

Saved in:
Bibliographic Details
Main Authors: S. Yu. Martsevich, M. M. Lukyanov, M. M. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelnyy, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Smirnov, E. V. Kudryashov, I. V. Budaeva, E. S. Nikoshnova, O. E. Karpov, O. M. Drapkina
Format: Article
Language:English
Published: Столичная издательская компания 2022-01-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
hospital prospective registry
coronavirus infection
covid-19
community-acquired pneumonia
cardiovascular diseases
comorbidity
pharmacotherapy
outcomes
Online Access:https://www.rpcardio.online/jour/article/view/2633
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.rpcardio.online/jour/article/view/2633

Similar Items